A Randomized, Double-Blind, Double-Dummy Phase 3 Study to Evaluate the Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Compared to Lansoprazole 30 mg in the Treatment of Subjects With Erosive Esophagitis
收藏DataCite Commons2025-10-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007237/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to demonstrate the efficacy of vonoprazan (TAK-438) versus
lansoprazole in the treatment of erosive esophagitis classified as Los Angeles (LA)
classification grades A to D at Week 8.
提供机构：
Vivli
创建时间：
2021-06-25
